Fig1 (Figure1)
Lacosamide Tablet
Product Images NDC 71921-221
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 71921-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig2 (Figure2)
Container-label-100mg-60s-site-iii (Lacosamide 100 mg Site Iii)
Container-label-150mg-60s-site-iii (Lacosamide 150 mg Site Iii)
Container-label-200mg-60s-site-iii (Lacosamide 200 mg Site Iii)
This is a description of a medication called Lacosamide Tablets, USP. Each tablet contains 200 mg of Lacosamide, an active ingredient. The usual dosage information can be found in the package insert. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F) in accordance with USP Controlled Room Temperature guidelines. The medication is manufactured by Indoco Remedies Lid in Goa, India. Each patient receiving the medication must be provided with a Medication Guide. This medication requires a prescription and comes in a pack of 60 tablets. It is manufactured for Florida Pharmaceutical Products, LLC in Boca Raton, Florida. The dimensions of the tablet are approximately 45 x 15 mm.*
Container-label-50mg-60s-site-iii (Lacosamide 50 mg Site Iii)
Str (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
